Followers | 17 |
Posts | 2671 |
Boards Moderated | 0 |
Alias Born | 06/04/2020 |
Monday, April 18, 2022 3:17:46 PM
There will be little demand for Zimhi since the existing mousetrap is excellent. Zimhi's main 'injection' benefit is only that if administered IMMEDIATELY into over dosing patient.
Don't believe the hype. Tempol? COVID is old news. The holy grail? Not so much. Tiny study. Remember all the levels we broke through? Yeah, I do. Reverse spit coming? Massive dilution? Watch any bounce, they will take it right back down.
Analyst? What analyst!
Rolling Stones are old and they suck!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM